Ticker Details
Liquidia Technologies, Inc.
IPO Date:	July 23, 2018
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$6.14B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.48 | 3.74%
Avg Daily Range (30 D):	$3.33 | 4.11%
Avg Daily Range (90 D):	$2.32 | 3.48%

Institutional Daily Volume
Avg Daily Volume:	.78M
Avg Daily Volume (30 D):	1.38M
Avg Daily Volume (90 D):	1.47M

Trade Size
Avg Trade Size (Sh.):	91
Avg Trade Size (Sh.) (30 D):	52
Avg Trade Size (Sh.) (90 D):	55

Institutional Trades
Total Institutional Trades:	1,419
Avg Institutional Trade:	$3.29M
Avg Institutional Trade (30 D):	$5.55M
Avg Institutional Trade (90 D):	$7.4M
Avg Institutional Trade Volume:	.12M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$4.84M
Avg Closing Trade (30 D):	$13.85M
Avg Closing Trade (90 D):	$18.94M
Avg Closing Volume:	174.77K

News

Aug 14, 2026 @ 4:47 AM Why Liquidia Stock Was Diving This Week Source: Eric Volkman

Apr 8, 2026 @ 5:00 PM Interstitial Lung Disease Market to Witness Accele... Source: Delveinsight

Apr 5, 2026 @ 2:06 PM Liquidia's Chairman Sold Company Shares Worth $2.5... Source: Robert Izquierdo

Mar 28, 2026 @ 3:26 PM The Chief Commercial Officer of Liquidia (LQDA) So... Source: Cory Renauer

Sep 29, 2025 @ 12:30 PM Liquidia to Present Clinical Data from ASCENT Tria... Source: Globe Newswire

Financials
	TTM	Q2 2026	Q1 2026
Basic EPS	$1.57	$.84	$.6
Diluted EPS	$1.39	$.74	$.52
Revenue	$450.91M	$171.68M	$132.87M
Gross Profit
Net Income / Loss	$138.61M	$74.72M	$52.86M
Operating Income / Loss	$168.58M	$85.52M	$61.5M
Cost of Revenue
Net Cash Flow	$110.76M	$61.4M	$32.11M
PE Ratio